Reverse transcriptase (RT) is an essential enzyme for replication of retroviruses, catalyzing the synthesis of proviral DNA by using genomic RNA as a template (41) . This enzyme has proven to be an attractive target in retroviral chemotherapy, as the RT from human immunodeficiency virus type 1 (HIV) can be selectively inhibited by the active form of competitive (12, 16, 20, 22) and noncompetitive (38, 42) inhibitors. RT exists as a bifunctional enzyme, showing both DNA polymerase activity and an RNase H activity that hydrolyzes the RNA of RNA-DNA hybrids (2, 25) . This activity resides in the C-terminal domain of RT, as demonstrated by homology with Escherichia coli RNase H (13) , as well as analysis of deletion mutants (9, 14) , point mutagenesis (24, 33, 34) , and limited proteolysis (15, 43) . RNase H is required for several steps in provirus formation, including degradation of RNA in transitional RNA-DNA hybrids (18, 19) , generation of an RNA primer for synthesis of plusstrand DNA (32) , and removal of tRNA and plus-strand primers (6, 30) . The central role of RNase H in provirus formation makes this unique activity a potential target for AIDS chemotherapy (11, 17, 23, 26, 37) .
Feline immunodeficiency virus (FIV) is a retrovirus that has been isolated from domestic cats showing an AIDS-like disorder (31, 44) . This lentivirus shows considerable similarity to HIV with respect to morphology, cell tropism, and pathogenesis (4, 31) . The RT from FIV shows a high degree of similarity with HIV RT, with greater than 45% homology at the genome sequence level (39) . We purified FIV RT (28) and have shown it to be nearly identical to HIV RT in template preference, divalent metal requirement, and sensitivity to active forms of several important antiviral compounds (27, 29 HIV RNase H activity in vitro (26) and HIV replication in cultured cells (1, 5, 21) .
The FIV RT was purified as previously reported (28) . HIV RT was kindly provided by Stephen Hughes (National Cancer Institute, Frederick, Md.). This recombinant HIV RT has been previously described (7, 10) and has been shown to be enzymatically indistinguishable from the virionassociated enzyme (35) . FIV and HIV RTs each displayed single bands with molecular weights of 67,000 and 66,000, respectively, when subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis. RNA polymerase from E. coli was obtained from Boehringer Mannheim.
The in vitro assay used to quantitate RNase H activity was identical to that reported by Starnes and Cheng (37) . The substrate utilized in this assay was 3H-labeled RNA transcribed from poly(dC) or poly(dT) templates with E. coli RNA polymerase. RNA-DNA hybrids were purified by Sephadex G-50 chromatography and phenol-chloroform extraction. Final hybrid preparations yielded approximately 460,000 cpm/nmol of GMP or AMP. Reaction mixtures (50 ,u) for determination of Michaelis and inhibition (K,) constants were incubated for 20 min at 37°C; for all other reactions, incubations were 30 min. Each reaction was initiated by adding 0.5 U of RNase H and terminated by adding an equal volume of ice-cold 7% perchloric acid. Aliquots (75 ,ul) were counted by liquid scintillation spectrometry in 10 ml of scintillation cocktail. One unit of RNase H activity is defined as the amount of enzyme that produces 1 nmol of acid-soluble ribonucleotide per hour at 37°C. RT activity was assayed as previously described (28) (Fig. 2) . Direct comparison showed that the HIV enzyme displayed a similar preference, confirming earlier results reported by Starnes and Cheng (37) . Both enzymes showed nearly identical ratios of RNase H activity to RT activity (ca. 0.1 U of RNase H per U of RT) when hydrolyzing the preferred substrate.
To characterize products from the action of FIV RNase H, approximately 100,000 cpm of [32P]poly(rG) poly(dC) substrate was incubated with 0.25 U of FIV RNase H in a 25-pl volume under optimal assay conditions. Reactions were terminated by adding 25 pl of 20 mM citrate buffer (pH 5.0) containing 7.0 M urea and 1.0 mM EDTA, and the mixtures were immediately applied to a 17.5% polyacrylamide-urea DNA sequencing gel (40) . GMP standards and RNA ladders were generated by complete or limited (3) base hydrolysis of a [32P]RNA DNA hybrid. Incubation with FIV RNase H resulted in the appearance of several bands, ranging from 1 to 6 nucleotides in length (Fig. 3) H with respect to substrate utilization and product formation, utilizing poly(rA) poly(dT) at a rate much greater than poly(rG) -poly(dC) (2, 43) and hydrolyzing substrate into products between 2 to 10 nucleotides in size (2, 8) . The Moloney murine leukemia virus RNase H shows a substrate specificity similar to that of HIV (43) , but the activity is Mn2" dependent (8) and it hydrolyzes homopolymeric hybrids into products greater than 10 to 20 nucleotides in length (8) . Our results demonstrate that the FIV RT-associated RNase H is very similar to the RNase H from HIV with respect to ion requirements, substrate preference, catalytic activity, and sensitivity to polyanionic inhibitors. As RNase H-targeted inhibitors become available for chemotherapeutic studies, animal models will greatly facilitate design and development. On the basis of our results, the FIV RNase H appears to be sufficiently similar to the same activity from HIV to warrant further development of FIV as a retrovirus model for chemotherapy of AIDS.
